Mast Cell-Mediated Antigen Presentation Regulates CD8+ T Cell Effector Functions

Immunity

Volumn 31, Issue 4, 2009, Pages 665-676

  Stelekati, Erietta ^a   Bahri, Rajia ^a   D'Orlando, Orietta ^a   Orinska, Zane ^a   Mittrücker, Hans Willi ^b   Langenhaun, Rabea ^a   Glatzel, Markus ^b   Bollinger, Annalena ^a   Paus, Ralf ^c,d   Bulfone Paus, Silvia ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

CD137 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OSTEOPONTIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL INTERACTION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD137; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; CHEMOKINE CCL3; COCULTURE TECHNIQUES; CROSS-PRIMING; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; GRANZYMES; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON-GAMMA; INTERLEUKIN-2; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOPONTIN; OVALBUMIN; PEPTIDE FRAGMENTS;

EID: 70349756896     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.08.022     Document Type: Article

References (61)

1. Andersen M.H., Schrama D., Straten P., and Becker J.C. Cytotoxic T cells. J. Invest. Dermatol. 126 (2006) 32-41
2. Banovac K., Neylan D., Leone J., Ghandur-Mnaymneh L., and Rabinovitch A. Are the mast cells antigen presenting cells?. Immunol. Invest. 18 (1989) 901-906
3. Bennett J.L., Blanchet M.R., Zhao L., Zbytnuik L., Antignano F., Gold M., Kubes P., and McNagny K.M. Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J. Immunol. 182 (2009) 5507-5514
4. Bernhard H., Huseby E.S., Hand S.L., Lohmann M., Batten W.Y., Disis M.L., Gralow J.R., Meyer zum Büschenfelde K.H., Ohlén C., and Cheever M.A. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression. Immunobiology 201 (2000) 568-582
5. Burd P.R., Rogers H.W., Gordon J.R., Martin C.A., Jayaraman S., Wilson S.D., Dvorak A.M., Galli S.J., and Dorf M.E. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170 (1989) 245-257
6. Burkett M.W., Shafer-Weaver K.A., Strobl S., Baseler M., and Malyguine A. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J. Immunother. 28 (2005) 396-402
7. Caron G., Delneste Y., Roelandts E., Duez C., Herbault N., Magistrelli G., Bonnefoy J.Y., Pestel J., and Jeannin P. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol. 166 (2001) 6000-6006
8. Dabak D.O., Aydin G., and Ozguner M. Dynamics of mast cells in lymph node following antigenic stimulation. Anat. Histol. Embryol. 33 (2004) 5-10
9. Foulds K.E., Zenewicz L.A., Shedlock D., Jiang J., Troy A.E., and Shen H. CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168 (2002) 1528-1532
10. Fox C.C., Jewell S.D., and Whitacre C.C. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell. Immunol. 158 (1994) 253-264
11. Frandji P., Oskeritzian C., Cacaraci F., Lapeyre J., Peronet R., David B., Guillet J.G., and Mecheri S. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151 (1993) 6318-6328
12. Galli S.J., Grimbaldeston M., and Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 8 (2008) 478-486
13. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
14. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.B., Brunner T., Blasey H., Life P., Talabot D., Flores-Romo L., Thompson J., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365 (1993) 340-343
15. Gekara N.O., and Weiss S. Mast cells initiate early anti-Listeria host defences. Cell. Microbiol. 10 (2008) 225-236
16. Gilhar A., Paus R., and Kalish R.S. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J. Clin. Invest. 8 (2007) 2019-2027
17. Gregory G.D., and Brown M.A. Mast cells in allergy and autoimmunity: implications for adaptive immunity. Methods Mol. Biol. 315 (2006) 35-50
18. Gregory G.D., Robbie-Ryan M., Secor V.H., Sabatino J.J., and Brown M.A. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35 (2005) 3478-3486
19. Heib V., Becker M., Warger T., Rechtsteiner G., Tertilt C., Klein M., Bopp T., Taube C., Schild H., Schmitt E., et al. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 110 (2007) 946-953
20. Heine H., Gronow S., Zamyatina A., Kosma P., and Brade H. Investigation on the agonistic and antagonistic biological activities of synthetic Chlamydia lipid A and its use in in vitro enzymatic assays. J. Endotoxin Res. 13 (2007) 126-132
21. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
22. Huff T.F., and Lantz C.S. Culture of mast cells. In: Lefkovits I. (Ed). The Immunology Methods Manual (1997), Academic Press, San Diego, U.S.A. 1393-1398
23. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., and Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007) 74-83
24. Hurtado J.C., Kim S.H., Pollok K.E., Lee Z.H., and Kwon B.S. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol. 155 (1995) 3360-3367
25. Kashiwakura J., Yokoi H., Saito H., and Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173 (2004) 5247-5257
26. Kellner A., Matschke J., Bernreuther C., Moch H., Ferrer I., and Glatzel M. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann. Neurol. 65 (2009) 24-31
27. Koller B.H., and Smithies O. Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86 (1989) 8932-8935
28. Lutz M.B., Kukutsch N., Ogilvie A.L., Rössner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
29. Malaviya R., Twesten N.J., Ross E.A., Abraham S.N., and Pfeifer J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156 (1996) 1490-1496
30. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4 (2004) 787-799
31. Metz M., and Maurer M. Mast cells: Key effector cells in immune responses. Trends Immunol. 28 (2007) 234-241
32. McLachlan J.B., Hart J.P., Pizzo S.V., Shelburne C.P., Staats H.F., Gunn M.D., and Abraham S.N. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4 (2003) 1199-1205
33. Mekori Y.A., and Metcalfe D.D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104 (1999) 517-523
34. Nagasaka A., Matsue H., Matsushima H., Aoki R., Nakamura Y., Kambe N., Kon S., Uede T., and Shimada S. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur. J. Immunol. 38 (2008) 489-499
35. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176 (2006) 2238-2248
36. Nakae S., Suto H., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 102 (2005) 6467-6472
37. Nishimoto H., Lee S.W., Hong H., Potter K.G., Maeda-Yamamoto M., Kinoshita T., Kawakami Y., Mittler R.S., Kwon B.S., Ware C.F., et al. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106 (2005) 4241-4248
38. Okumura S., Kashiwakura J., Tomita H., Matsumoto K., Nakajima T., Saito H., and Okayama Y. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 102 (2003) 2547-2554
39. Orinska Z., Bulanova E., Budagian V., Metz M., Maurer M., and Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106 (2005) 978-987
40. Orinska Z., Maurer M., Mirghomizadeh F., Bulanova E., Metz M., Nashkevich N., Schiemann F., Schulmistrat J., Budagian V., Giron-Michel J., et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13 (2007) 927-934
41. Ott V.L., Cambier J.C., Kappler J., Marrack P., and Swanson B.J. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat. Immunol. 4 (2003) 974-981
42. Poncet P., Arock M., and David B. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation. J. Leukoc. Biol. 66 (1999) 105-112
43. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., and Germain R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6 (1997) 715-726
44. Rückert R., Brandt K., Bulanova E., Mirghomizadeh F., Paus R., and Bulfone-Paus S. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur. J. Immunol. 33 (2003) 3493-3503
45. Rumsaeng V., Cruikshank W.W., Foster B., Prussin C., Kirshenbaum A.S., Davis T.A., Kornfeld H., Center D.M., and Metcalfe D.D. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J. Immunol. 159 (1997) 2904-2910
46. Sayed B.A., Christy A., Quirion M.R., and Brown M.A. The master switch: The role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 26 (2008) 705-739
47. Schorle H., Holtschke T., Hünig T., Schimpl A., and Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352 (1991) 621-624
48. Schott E., Bertho N., Ge Q., Maurice M.M., and Ploegh H.L. Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules. Proc. Natl. Acad. Sci. USA 99 (2002) 13735-13740
49. Secor V.H., Secor W.E., Gutenkust C.A., and Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 (2000) 813-822
50. Skokos D., Botros H.G., Demeure C., Morin J., Peronet R., Birkenmeier G., Boudaly S., and Mecheri S. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J. Immunol. 170 (2003) 3037-3045
51. Stelekati E., Orinska Z., and Bulfone-Paus S. Mast cells in allergy: Innate instructors of adaptive responses. Immunobiology 212 (2007) 505-519
52. Su M.W., Walden P.R., Golan D.B., and Eisen H.N. Cognate peptide-induced destruction of CD8+ cytotoxic T lymphocytes is due to fratricide. J. Immunol. 151 (1993) 658-667
53. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., and Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587
54. Sundstrom J.B., Ellis J.E., Hair G.A., Kirshenbaum A.S., Metcalfe D.D., Yi H., Cardona A.C., Lindsay M.K., and Ansari A.A. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109 (2007) 5293-5300
55. Tanzola M.B., Robbie-Ryan M., Gutekunst C.A., and Brown M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171 (2003) 4385-4391
56. Tkaczyk C., Villa I., Peronet R., David B., Chouaib S., and Mecheri S. In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation. J. Allergy Clin. Immunol. 105 (2000) 134-142
57. Unanue E.R. Ito cells, stellate cells, and myofibroblasts: new actors in antigen presentation. Immunity 26 (2007) 9-10
58. Wang H.W., Tedla N., Lloyd A.R., Wakefield D., and McNeil P.H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102 (1998) 1617-1626
59. Winau F., Hegasy G., Weiskirchen R., Weber S., Cassan C., Sieling P.A., Modlin R.L., Liblau R.S., Gressner A.M., and Kaufmann S.H.E. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26 (2007) 117-129
60. Wong G.H., Clark-Lewis I., McKimm-Breschkin J.L., and Schrader J.W. Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc. Natl. Acad. Sci. USA 79 (1982) 6989-6993
61. Zijlstra M., Bix M., Simister N.E., Loring J.M., Raulet D.H., and Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344 (1990) 742-746